Please ensure Javascript is enabled for purposes of website accessibility
Accueil > Products > Anticorps > Biosimilaires

Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO) (HX959036)

Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Prix(USD) :
Spécification :
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Nombre :
Contactez-nous
  • Aperçu

  • Images

  • Reférences

  • Fiche technique

  • SDS

Aperçu
Numéro de catalogueHX959036
Description
Alnuctamab (HX959036) is a research-grade recombinant antibody targeting CD269. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactivité des espècesHuman
ApplicationsELISA, Bioactivity: FCM, Functional assay, Research in vivo
Espèce hôteHuman
ClonalitéMonoclonal
IsotypeIgG1;IgG1, Kappa;Lambda
Cible B-cell maturation protein, BCM, BCMA, CD269, TNFRSF17, Tumor necrosis factor receptor superfamily member 17, CD3E, CD3e, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 epsilon chain, T3E
Niveau d'endotoxines < 10 EU/mg
Pureté >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Numéro d'accès Q02223 & P07766
Forme Liquid
Tampon de stockage 0.01M PBS pH 7.4.

Reférez-vous aux informations spécifiques sur le tampon dans la copie papier du datasheet ou dans le COA spécifique au lot.

Stabilité et stockage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Noms alternatifsTrivalentBispecific, CC-93269, EM-901, 2296827-07-9
ContexteTeclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
Human IgG1 (E356D/M358L), kappa Recombinant Isotype Control Antibody (HyHEL-10) (HV080013)
Anti-LASV GPC Recombinant Antibody (Fab 37.7) (VK453013)
Images
  • Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)

    Bioactivity

    Detects Human CD269/TNFRSF17/BCMA in indirect ELISAs.

  • Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)

    SDS-PAGE

    SDS-PAGE for Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)

Reférences
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommandation

Contactez-nous pour les devis personnalisés, les demandes en gros et tout autre problème.

Courrier : [email protected]

Liste des distributeurs